[1]易晓明,曾 芬.甲泼尼龙治疗SCAP的效果及其对降钙素原水平的影响[J].医学信息,2019,32(21):145-146.[doi:10.3969/j.issn.1006-1959.2019.21.047]
　YI Xiao-ming,ZENG Fen.Effect of Methylprednisolone on SCAP and its Effect on Procalcitonin Level[J].Journal of Medical Information,2019,32(21):145-146.[doi:10.3969/j.issn.1006-1959.2019.21.047]
点击复制

甲泼尼龙治疗SCAP的效果及其对降钙素原水平的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年21期
页码:
145-146
栏目:
药物与临床
出版日期:
2019-11-01

文章信息/Info

Title:
Effect of Methylprednisolone on SCAP and its Effect on Procalcitonin Level
文章编号:
1006-1959（2019）21-0145-02
作者:
易晓明; 曾 芬
（江西宜春市第二人民医院呼吸内科，江西 宜春 336000）
Author(s):
YI Xiao-ming; ZENG Fen
(Department of Respiratory Medicine,the Second People's Hospital of Yichun City,Yichun 336000,Jiangxi,China)
关键词:
肺炎; SCAP; PCT; 甲泼尼龙; 糖皮质激素
Keywords:
Pneumonia; SCAP; PCT; Methylprednisolone; Glucocorticoid
分类号:
R563.1
DOI:
10.3969/j.issn.1006-1959.2019.21.047
文献标志码:
A
摘要:
目的 探讨糖皮质激素对重症社区获得性肺炎（SCAP）治疗效果及血清降钙素原（PCT）水平的影响。方法 选取我院2017年1月~2019年1月收治的SCAP患者120例，按照随机数字表法分为对照组与研究组，每组60例。对照组予以常规对症治疗，研究组在对照组基础上加用甲泼尼龙治疗。比较两组临床疗效、二重感染率、病死率、住院时间及PCT水平变化。结果 研究组总有效率为88.33%，高于对照组的71.67%，差异具有统计学意义（P＜0.05）。治疗后，研究组PCT为（0.40±0.27）μg/L，低于对照组的（1.05±0.587）μg/L，差异具有统计学意义（P＜0.05）。两组病死率比较，差异无统计学意义（P＞0.05）；研究组再感染率为18.33%、住院时间为（12.17±3.45）d，分别低于对照组的36.67%、（17.26±5.19）d，差异有统计学意义（P＜0.05）。结论 甲泼尼龙有助于提高SCAP的临床疗效，降低PCT水平，有效缩短住院治疗时间，改善预后。
Abstract:
Objective To investigate the effects of glucocorticoids on the treatment of severe community acquired pneumonia (SCAP) and serum procalcitonin (PCT) levels. Methods A total of 120 SCAP patients admitted to our hospital from January 2017 to January 2019 were randomly divided into the control group and the study group, with 60 cases in each group. The control group received conventional symptomatic treatment, and the study group was treated with methylprednisolone on the basis of the control group. The clinical efficacy, double infection rate, mortality, hospitalization time and PCT level were compared between the two groups. Results The total effective rate of the study group was 88.33%, which was higher than that of the control group 71.67%,the difference was statistically significant (P<0.05). After treatment, the PCT of the study group was (0.40±0.27) μg/L, which was lower than that of the control group (1.05±0.587) μg/L,the difference was statistically significant (P<0.05). There was no significant difference in mortality between the two groups (P>0.05). The reinfection rate of the study group was 18.33% and the hospitalization time was (12.17±3.45) d, which was lower than the control group 36.67%, (17.26±5.19)d,the difference was statistically significant(P<0.05).Conclusion Methylprednisolone can improve the clinical efficacy of SCAP, reduce the level of PCT, effectively shorten the hospitalization time and improve the prognosis.

参考文献/References:

[1]洪向春,闻文波,刘姗姗,等.雾化吸入与全身应用糖皮质激素对老年AECOPD患者的临床疗效比较及对PCT和hs-CRP表达的影响[J].中国生化药物杂志,2017(3):407-409. [2]赵德军,陈琳玲,汤军华,等.糖皮质激素治疗重症社区获得性肺炎患者的临床疗效与对血清血管紧张素Ⅱ水平的影响[J].中华医院感染学杂志,2017(15):3438-3441. [3]谢君杰,易汛,徐昉,等.临床肺部感染评分和降钙素原对评估老年重症社区获得性肺炎患者病情和预后的意义[J].中华实验和临床感染病杂志(电子版),2018,12(1):61-64. [4]徐建新.重症社区获得性肺炎采用盐酸氨溴索联合头孢哌酮舒巴坦钠治疗的效果观察[J].医学信息,2014,27(33):319-320. [5]隋东江,张伟,李伟生,等.糖皮质激素治疗重症社区获得性肺炎的疗效及对C反应蛋白水平的影响[J].临床肺科杂志,2013,18(7):1171-1173.

相似文献/References:

[1]李绪定.碳青霉烯类治疗铜绿假单胞菌肺炎的临床效果分析[J].医学信息,2018,31(13):134.[doi:10.3969/j.issn.1006-1959.2018.13.039]
　LI Xu-ding.Clinical Effect of Carbapenem in the Treatment of Pseudomonas Aeruginosa Pneumonia[J].Journal of Medical Information,2018,31(21):134.[doi:10.3969/j.issn.1006-1959.2018.13.039]
[2]远 颖.黄芪注射液治疗儿童肺炎的Meta分析[J].医学信息,2019,32(02):95.[doi:10.3969/j.issn.1006-1959.2019.02.027]
　YUAN Ying.Meta-analysis of Huangqi Injection in the Treatment of Children with Pneumonia[J].Journal of Medical Information,2019,32(21):95.[doi:10.3969/j.issn.1006-1959.2019.02.027]
[3]阳池娇,陈进喜,白 珺.儿童7型腺病毒肺炎特点分析[J].医学信息,2020,33(02):121.[doi:10.3969/j.issn.1006-1959.2020.02.035]
　YANG Chi-jiao,CHEN Jin-xi,BAI Jun.Characteristics Analysis of Adenovirus Type 7 Pneumonia in Children[J].Journal of Medical Information,2020,33(21):121.[doi:10.3969/j.issn.1006-1959.2020.02.035]
[4]于 波.静脉注射丙种球蛋白治疗早产儿肺炎临床疗效[J].医学信息,2020,33(04):149.[doi:10.3969/j.issn.1006-1959.2020.04.048]
　YU Bo.Clinical Efficacy of Intravenous Gamma Globulin in Premature Infants with Pneumonia[J].Journal of Medical Information,2020,33(21):149.[doi:10.3969/j.issn.1006-1959.2020.04.048]
[5]郭 婷,张思琪.2019年12月~2020年3月新型冠状病毒肺炎主题研究的文献计量学分析[J].医学信息,2020,33(12):1.[doi:10.3969/j.issn.1006-1959.2020.12.001]
　GUO Ting,ZHANG Si-qi.Bibliometric Analysis of the Theme Research on Novel Coronavirus Pneumonia from December 2019 to March 2020[J].Journal of Medical Information,2020,33(21):1.[doi:10.3969/j.issn.1006-1959.2020.12.001]
[6]黄永辉,吕 刚.纤维支气管镜下注入依替米星治疗脑卒中后肺炎的疗效[J].医学信息,2020,33(15):146.[doi:10.3969/j.issn.1006-1959.2020.15.046]
　HUANG Yong-hui,LYU Gang.Efficacy of Injecting Etimicin under Fiberoptic Bronchoscopein the Treatment of Pneumonia After Stroke[J].Journal of Medical Information,2020,33(21):146.[doi:10.3969/j.issn.1006-1959.2020.15.046]
[7]马 斌,柴 智,王金虹.基于CNKI的中医诊断冠状病毒肺炎研究的文献计量学分析[J].医学信息,2020,33(21):4.[doi:10.3969/j.issn.1006-1959.2020.21.002]
　MA Bin,CHAI Zhi,WANG Jin-hong.Bibliometric Analysis of Research Literature on Diagnosis of Coronavirus Pneumonia in Chinese Medicine Based on CNKI[J].Journal of Medical Information,2020,33(21):4.[doi:10.3969/j.issn.1006-1959.2020.21.002]
[8]葛盘春.阿莫西林克拉维酸钾治疗儿童肺炎的临床疗效[J].医学信息,2022,35(06):135.[doi:10.3969/j.issn.1006-1959.2022.06.034]
　GE Pan-chun.Clinical Efficacy of Amoxicillin and Clavulanate Potassium in the Treatment of Pneumonia in Children[J].Journal of Medical Information,2022,35(21):135.[doi:10.3969/j.issn.1006-1959.2022.06.034]

更新日期/Last Update: 2019-11-01